In fact, the first genetic mouse model of atherosclerosis with advanced lesions—the APOE-deficient mouse—was generated in the Breslow and Maeda laboratories in the early 1990's in part to mimic the impaired clearance of RLPs and severe premature coronary and peripheral vessel risk observed in patients with remnant removal disease (33, 34). This evidence concerns the gene APOE and atherosclerosis.